FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2181931892> ?p ?o ?g. }

• W2181931892 endingPage "46" @default.
• W2181931892 startingPage "939" @default.
• W2181931892 abstract "Neoadjuvant chemotherapy (NACT) is well established as the standard of care and initial management of choice for patients with advanced breast cancer (ABC). The response is however not uniform. The present study was an endeavor to develop a clinically applicable tool based on the available clinico-pathological data in the routine clinical setting to predict response to chemotherapy in breast cancer in a developing country. From 1st June 2005 to 30th June 2007, 149 patients registered at INMOL hospital with ABC at initial diagnosis having tumor size 5 cm or more and treated with FAC as NACT were prospectively included in the study to analyze association of response after first cycle of chemotherapy (initial clinical response) with that after the third cycle. Tumor measurements were done at base line (before starting chemotherapy), three weeks after the first course of chemotherapy and three weeks after the third course. Percentage change was calculated for the latter two stages. Clinical response was assessed according to WHO/UICC criteria. Pathological complete response (pCR) was based on the histopathology of the operative specimen after NACT. 67.1% patients (cCR 7.4%+cPR 59.7%) responded to chemotherapy while 32.9% (cSD 23.5%+cPD 9.4%) did not. pCR rate was 4%. No patient had initial clinical complete response while 23% had icPR, 74% had icSD and 3% had icPD. All patients with icPR responded to NACT (cCR 29%+cPR 71%) while 60% of icSD responded to chemotherapy (cCR 1%+cPR 59%) and 40% of icSD failed to respond (cSD 31%+cPD 9%). All patients with icPD developed cPD. The high sensitivity of initial clinical response for prediction of cCR and 100% specificity of icPD for prediction of cPD favors its incorporation in clinical practice, as an early predictor of response to NACT in ABC patients." @default.
• W2181931892 created "2016-06-24" @default.
• W2181931892 creator A5004919897 @default.
• W2181931892 creator A5020458179 @default.
• W2181931892 creator A5033638876 @default.
• W2181931892 creator A5072140693 @default.
• W2181931892 creator A5074903920 @default.
• W2181931892 date "2011-01-01" @default.
• W2181931892 modified "2023-09-23" @default.
• W2181931892 title "Initial clinical response to neoadjuvant chemotherapy: an in-vivo chemosensitivity test for efficacy in patients with advanced breast cancer." @default.
• W2181931892 cites W1223098551 @default.
• W2181931892 cites W127046636 @default.
• W2181931892 cites W1576023464 @default.
• W2181931892 cites W1644997609 @default.
• W2181931892 cites W166169566 @default.
• W2181931892 cites W1863328694 @default.
• W2181931892 cites W1961026612 @default.
• W2181931892 cites W1983546759 @default.
• W2181931892 cites W1992546083 @default.
• W2181931892 cites W2005849136 @default.
• W2181931892 cites W2013326703 @default.
• W2181931892 cites W2019294563 @default.
• W2181931892 cites W2020830322 @default.
• W2181931892 cites W2027762699 @default.
• W2181931892 cites W2030273025 @default.
• W2181931892 cites W2043630729 @default.
• W2181931892 cites W2058681718 @default.
• W2181931892 cites W2063804661 @default.
• W2181931892 cites W2065511526 @default.
• W2181931892 cites W2071521600 @default.
• W2181931892 cites W2074565257 @default.
• W2181931892 cites W2075191363 @default.
• W2181931892 cites W2075771094 @default.
• W2181931892 cites W2076619636 @default.
• W2181931892 cites W2106663556 @default.
• W2181931892 cites W2109079833 @default.
• W2181931892 cites W2116641231 @default.
• W2181931892 cites W2118806120 @default.
• W2181931892 cites W2126863375 @default.
• W2181931892 cites W2127650183 @default.
• W2181931892 cites W2132200264 @default.
• W2181931892 cites W2133351546 @default.
• W2181931892 cites W2135303651 @default.
• W2181931892 cites W2136613143 @default.
• W2181931892 cites W2138192032 @default.
• W2181931892 cites W2138361287 @default.
• W2181931892 cites W2138734774 @default.
• W2181931892 cites W2140067705 @default.
• W2181931892 cites W2140264773 @default.
• W2181931892 cites W2143910081 @default.
• W2181931892 cites W2153369531 @default.
• W2181931892 cites W2153584585 @default.
• W2181931892 cites W2154419931 @default.
• W2181931892 cites W2155803397 @default.
• W2181931892 cites W2157962151 @default.
• W2181931892 cites W2163403096 @default.
• W2181931892 cites W2165335733 @default.
• W2181931892 cites W2167805334 @default.
• W2181931892 cites W2171958606 @default.
• W2181931892 cites W2187642494 @default.
• W2181931892 cites W2189122853 @default.
• W2181931892 cites W2241184209 @default.
• W2181931892 cites W2412387474 @default.
• W2181931892 cites W2415374501 @default.
• W2181931892 cites W2430820974 @default.
• W2181931892 cites W2120627772 @default.
• W2181931892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21790230" @default.
• W2181931892 hasPublicationYear "2011" @default.
• W2181931892 type Work @default.
• W2181931892 sameAs 2181931892 @default.
• W2181931892 citedByCount "3" @default.
• W2181931892 countsByYear W21819318922016 @default.
• W2181931892 countsByYear W21819318922017 @default.
• W2181931892 countsByYear W21819318922018 @default.
• W2181931892 crossrefType "journal-article" @default.
• W2181931892 hasAuthorship W2181931892A5004919897 @default.
• W2181931892 hasAuthorship W2181931892A5020458179 @default.
• W2181931892 hasAuthorship W2181931892A5033638876 @default.
• W2181931892 hasAuthorship W2181931892A5072140693 @default.
• W2181931892 hasAuthorship W2181931892A5074903920 @default.
• W2181931892 hasConcept C121608353 @default.
• W2181931892 hasConcept C126322002 @default.
• W2181931892 hasConcept C141071460 @default.
• W2181931892 hasConcept C143998085 @default.
• W2181931892 hasConcept C2776694085 @default.
• W2181931892 hasConcept C530470458 @default.
• W2181931892 hasConcept C535046627 @default.
• W2181931892 hasConcept C71924100 @default.
• W2181931892 hasConceptScore W2181931892C121608353 @default.
• W2181931892 hasConceptScore W2181931892C126322002 @default.
• W2181931892 hasConceptScore W2181931892C141071460 @default.
• W2181931892 hasConceptScore W2181931892C143998085 @default.
• W2181931892 hasConceptScore W2181931892C2776694085 @default.
• W2181931892 hasConceptScore W2181931892C530470458 @default.
• W2181931892 hasConceptScore W2181931892C535046627 @default.
• W2181931892 hasConceptScore W2181931892C71924100 @default.
• W2181931892 hasIssue "4" @default.
• W2181931892 hasLocation W21819318921 @default.

• next